Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update

    NEXT STORY
    Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
    PREV STORY
    ContraFect Reports Second Quarter 2019 Financial Results and Provides Business Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Press news Biocartis Group NV: Biocartis Announces Ten Idylla™ Studies to be Published at Virtual AMP (US) Annual Meeting

    author_avatar
    NASDAQ Market News

    XBiotech Completes Dosing of Subjects in PK Study Being Conducted in Connection with European Marketing Application

    AUSTIN, Texas, Feb. 22, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced that all ...

    author_avatar
    NASDAQ Market News

    Cue Health Receives ISO 13485 Certification

    SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare ...

    author_avatar
    NASDAQ Market News